Verve Therapeutics Statistics
Total Valuation
AREN has a market cap or net worth of $321.04 million. The enterprise value is $438.07 million.
Important Dates
The next estimated earnings date is Monday, August 18, 2025, before market open.
| Earnings Date | Aug 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AREN has 47.56 million shares outstanding. The number of shares has increased by 67.64% in one year.
| Current Share Class | 47.56M |
| Shares Outstanding | 47.56M |
| Shares Change (YoY) | +67.64% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 3.31% |
| Owned by Institutions (%) | 4.77% |
| Float | 12.06M |
Valuation Ratios
The trailing PE ratio is 31.11 and the forward PE ratio is 9.38.
| PE Ratio | 31.11 |
| Forward PE | 9.38 |
| PS Ratio | 2.13 |
| Forward PS | 3.68 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 65.70 |
| EV / Sales | 3.40 |
| EV / EBITDA | 16.35 |
| EV / EBIT | 18.90 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.33
| Current Ratio | 0.33 |
| Quick Ratio | 0.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.38 |
| Debt / FCF | n/a |
| Interest Coverage | 1.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.33% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -452.60% |
| Revenue Per Employee | $650,409 |
| Profits Per Employee | $33,677 |
| Employee Count | 198 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 625.73 |
Taxes
In the past 12 months, AREN has paid $494,000 in taxes.
| Income Tax | 494,000 |
| Effective Tax Rate | 5.18% |
Stock Price Statistics
The stock price has increased by +694.12% in the last 52 weeks. The beta is 0.62, so AREN's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +694.12% |
| 50-Day Moving Average | 5.83 |
| 200-Day Moving Average | 3.12 |
| Relative Strength Index (RSI) | 56.97 |
| Average Volume (20 Days) | 170,205 |
Short Selling Information
The latest short interest is 664,960, so 1.40% of the outstanding shares have been sold short.
| Short Interest | 664,960 |
| Short Previous Month | 354,516 |
| Short % of Shares Out | 1.40% |
| Short % of Float | 5.52% |
| Short Ratio (days to cover) | 2.18 |
Income Statement
In the last 12 months, AREN had revenue of $128.78 million and earned $6.67 million in profits. Earnings per share was $0.16.
| Revenue | 128.78M |
| Gross Profit | 62.45M |
| Operating Income | 23.18M |
| Pretax Income | -139.31M |
| Net Income | 6.67M |
| EBITDA | 26.79M |
| EBIT | 23.18M |
| Earnings Per Share (EPS) | $0.16 |
Full Income StatementBalance Sheet
The company has $2.90 million in cash and $119.94 million in debt, giving a net cash position of -$117.04 million or -$2.46 per share.
| Cash & Cash Equivalents | 2.90M |
| Total Debt | 119.94M |
| Net Cash | -117.04M |
| Net Cash Per Share | -$2.46 |
| Equity (Book Value) | -125.95M |
| Book Value Per Share | -2.65 |
| Working Capital | -80.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.45 million and capital expenditures -$54,000, giving a free cash flow of -$10.50 million.
| Operating Cash Flow | -10.45M |
| Capital Expenditures | -54,000 |
| Free Cash Flow | -10.50M |
| FCF Per Share | -$0.22 |
Full Cash Flow StatementMargins
Gross margin is 48.50%, with operating and profit margins of 18.00% and 5.18%.
| Gross Margin | 48.50% |
| Operating Margin | 18.00% |
| Pretax Margin | 7.41% |
| Profit Margin | 5.18% |
| EBITDA Margin | 20.80% |
| EBIT Margin | 18.00% |
| FCF Margin | n/a |
Dividends & Yields
AREN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -67.64% |
| Shareholder Yield | -67.64% |
| Earnings Yield | 2.08% |
| FCF Yield | -3.27% |
Analyst Forecast
The average price target for AREN is $10.00, which is 48.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 48.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 9, 2022. It was a reverse split with a ratio of 1:22.
| Last Split Date | Feb 9, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:22 |
Scores
AREN has an Altman Z-Score of -4.76 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.76 |
| Piotroski F-Score | 5 |
